MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression.

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression.
• The miR-34 family is downregulated in advanced multiple myeloma (MM).
• A discrepancy exists between increased TP53 and decreased miR-34 in MM.

Purpose of the Study:

• To elucidate the mechanism of miRNA dysregulation in MM.
• To investigate the interaction between MYC and the TP53-miR34 axis.
• To understand MYC's role in suppressing p53-dependent miRNA expression.

Main Methods:

• Utilized nutlin-3 and Tet-on systems to induce wild-type p53 accumulation in human MM cell lines.
• Administered Myc inhibitors and employed the MYC-ER system for MYC activation/inhibition.
• Correlated TP53 and MYC levels with mature miR-34 expression in patient-derived plasma cells.

Main Results:

• Wild-type p53 accumulation upregulated miR-34 expression.
• Myc inhibition enhanced p53-induced miR-34 upregulation.
• Forced MYC activation suppressed p53-mediated miR-34 induction.
• TP53 and MYC showed negative correlation with miR-34 in MM patient samples.

Conclusions:

• MYC actively suppresses p53-dependent miRNA expression in MM.
• Inhibition of tumor-suppressive miRNAs by MYC contributes to MM development.
• Understanding this axis offers potential therapeutic targets for MM.